Howard/Hopkins Cancer Centers Partnership

霍华德/霍普金斯癌症中心合作伙伴关系

基本信息

  • 批准号:
    6335948
  • 负责人:
  • 金额:
    $ 73.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-07-13 至 2006-04-30
  • 项目状态:
    已结题

项目摘要

The regions served by the Howard University Cancer Center (HUCC) and Johns Hopkins Comprehensive Cancer Center (JHCCC), Maryland and the District of Columbia, have had among the highest cancer death rates in the United States for more than fifty years. Minority residents of these regions have been disproportionately affected by cancer, and cancer has become a leading cause of morbidity and mortality for African-Americans in both Baltimore, Maryland, and Washington, D.C. To address this problem, HUCC and JHCCC have embarked on a partnership to increase productive research in screening, diagnosis, prevention, treatment, and supportive care as it relates to cancer, with a special focus on cancer in African-Americans. The HUCC/JHCCC partnership, which began as a series of collaborative efforts involving faculty from each institution organized into groups targeting high priority areas, has been supported since September of 1999 by supplemental funds for the JHCCC core grant from the National Cancer Institute (NCI). The successes realized thus far during the planning phases of the HUCC/JHCCC partnership, with collaborative research progress in several areas, including prostate cancer, gastrointestinal cancers, and breast cancer, has promoted the submission of this grant in an attempt to secure funds to further augment partnership activities. The major aim of this grant proposal is to continue the development of a sustainable partnership between HUCC and JHCCC that enhances the research, training, education, and outreach missions of both institutions. To accomplish this goal, the HUCC/JHCCC partnership will work to build the research faculty and scientific programs at HUCC directed at cancer in African-Americans, to enhance population-based cancer studies at JHCCC involving African-Americans, to increase opportunities for research training and career development of African- American cancer researchers at HUCC, and to improve proposal seeks support for 3 research projects, 2 pilot research projects, 1 pilot educational program, and core infrastructure at HUCC, along with additional funds for further planning and development of the HUCC/JHCCC partnership. Over the last 5 years of support requested for the HUCC/JHCCC partnership, as these initial research and educational activities progress to complete for independent funding, new programs, and resources of high priority for development will be identified and supported.
由霍华德大学癌症中心(HUCC)和约翰霍普金斯综合癌症中心(JHCCC)、马里兰州和哥伦比亚特区服务的地区,在美国50多年来一直是癌症死亡率最高的地区之一。这些地区的少数民族居民受到癌症的影响不成比例,癌症已成为巴尔的摩、马里兰州和华盛顿,华盛顿特区非洲裔美国人发病率和死亡率的主要原因。为了解决这一问题,HUCC和JHCCC已开始合作,以增加与癌症有关的筛查、诊断、预防、治疗和支持性护理方面的富有成效的研究,特别关注非裔美国人的癌症。HUCC/JHCCC伙伴关系,开始作为一系列的合作努力,涉及教师从每个机构组织成针对高优先领域的群体,自1999年9月以来一直由国家癌症研究所(NCI)的JHCCC核心补助金的补充资金支持。迄今为止,在HUCC/JHCCC伙伴关系的规划阶段所取得的成功,以及在包括前列腺癌、胃肠癌和乳腺癌在内的几个领域的合作研究进展,促进了该赠款的提交,以确保资金进一步扩大伙伴关系活动。这项赠款提案的主要目的是继续发展HUCC和JHCCC之间的可持续伙伴关系,以加强这两个机构的研究,培训,教育和推广任务。为了实现这一目标,HUCC/JHCCC合作伙伴关系将致力于建立HUCC针对非洲裔美国人癌症的研究师资和科学计划,加强JHCCC涉及非洲裔美国人的基于人群的癌症研究,增加HUCC非洲裔美国人癌症研究人员的研究培训和职业发展机会,并改善对3个研究项目,2个试点研究项目,1个试点教育项目,以及HUCC的核心基础设施,沿着额外的资金,用于进一步规划和发展HUCC/JHCCC伙伴关系。在过去的5年中,HUCC/JHCCC伙伴关系所需的支持,随着这些初步的研究和教育活动的进展,独立的资金,新的计划和资源的高度优先发展将被确定和支持。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTIN D ABELOFF其他文献

MARTIN D ABELOFF的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTIN D ABELOFF', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    7250604
  • 财政年份:
    2006
  • 资助金额:
    $ 73.61万
  • 项目类别:
BIOSTATISTIC CORE
生物统计核心
  • 批准号:
    7250615
  • 财政年份:
    2006
  • 资助金额:
    $ 73.61万
  • 项目类别:
Planning and Evaluation Core
规划与评估核心
  • 批准号:
    7250605
  • 财政年份:
    2006
  • 资助金额:
    $ 73.61万
  • 项目类别:
DEVELOPMENTAL FUNDS
发展基金
  • 批准号:
    7304438
  • 财政年份:
    2006
  • 资助金额:
    $ 73.61万
  • 项目类别:
PLANNING AND EVALUATION
规划与评估
  • 批准号:
    7304433
  • 财政年份:
    2006
  • 资助金额:
    $ 73.61万
  • 项目类别:
RECRUITMENT CORE
招聘核心
  • 批准号:
    7250616
  • 财政年份:
    2006
  • 资助金额:
    $ 73.61万
  • 项目类别:
DEVELOPMENTAL CORE
发展核心
  • 批准号:
    7250606
  • 财政年份:
    2006
  • 资助金额:
    $ 73.61万
  • 项目类别:
SENIOR LEADERSHIP
高层领导
  • 批准号:
    7304424
  • 财政年份:
    2006
  • 资助金额:
    $ 73.61万
  • 项目类别:
Pilot Project 1: Molecular Profile of a Basal0Like Phenotype of Breast Cancer in
试点项目 1:乳腺癌 Basal0Like 表型的分子谱
  • 批准号:
    7250607
  • 财政年份:
    2006
  • 资助金额:
    $ 73.61万
  • 项目类别:
Howard/Hopkins Cancer Centers Partnership
霍华德/霍普金斯癌症中心合作伙伴关系
  • 批准号:
    6770099
  • 财政年份:
    2001
  • 资助金额:
    $ 73.61万
  • 项目类别:

相似海外基金

KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH
KEMRI-PHRD UG1 级联网络单元:艾滋病毒感染女性的宫颈癌预防研究
  • 批准号:
    10763054
  • 财政年份:
    2023
  • 资助金额:
    $ 73.61万
  • 项目类别:
Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador
制定 HPV 耻辱评估量表和减少耻辱干预措施,以改善萨尔瓦多的宫颈癌预防
  • 批准号:
    10844859
  • 财政年份:
    2023
  • 资助金额:
    $ 73.61万
  • 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
  • 批准号:
    10829054
  • 财政年份:
    2023
  • 资助金额:
    $ 73.61万
  • 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
  • 批准号:
    10758129
  • 财政年份:
    2023
  • 资助金额:
    $ 73.61万
  • 项目类别:
TOPIC 453: THE PERFECT MEDICAL ASSISTANT FOR CANCER PREVENTION WITHIN PRIMARY CARE
主题 453:初级保健中预防癌症的完美医疗助手
  • 批准号:
    10931123
  • 财政年份:
    2023
  • 资助金额:
    $ 73.61万
  • 项目类别:
PIECES – Towards Large-Scale Adaption and Tailored Implementation of Evidence-Based Primary Cancer Prevention Programmes in Europe and Beyond
部分内容 — 致力于在欧洲及其他地区大规模适应和定制实施循证初级癌症预防计划
  • 批准号:
    10079747
  • 财政年份:
    2023
  • 资助金额:
    $ 73.61万
  • 项目类别:
    EU-Funded
Co-creating a community engagement knowledge translation summit on improving cancer prevention and screening in Canada
共同创建社区参与知识翻译峰会,以改善加拿大的癌症预防和筛查
  • 批准号:
    480839
  • 财政年份:
    2023
  • 资助金额:
    $ 73.61万
  • 项目类别:
    Miscellaneous Programs
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
  • 批准号:
    10737017
  • 财政年份:
    2023
  • 资助金额:
    $ 73.61万
  • 项目类别:
Using mHealth to investigate intersectionality and health behaviors: Implications for conceptual models and cancer prevention interventions for marginalized populations
使用移动医疗研究交叉性和健康行为:对边缘化人群的概念模型和癌症预防干预措施的影响
  • 批准号:
    10746886
  • 财政年份:
    2023
  • 资助金额:
    $ 73.61万
  • 项目类别:
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE REGULATORY SERVICES AND TECHNICAL SUPPORT TO THE DIVISION OF CANCER PREVENTION (DCP) AT THE NATIONAL CANCER INSTITUTE (NCI). NCI AND DCP HAVE A RECURRING
此要求的目的是为国家癌症研究所 (NCI) 的癌症预防部门 (DCP) 提供监管服务和技术支持。
  • 批准号:
    10974513
  • 财政年份:
    2023
  • 资助金额:
    $ 73.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了